ask="11.25"
ask_size="900"
average_daily_volume="9139"
bid="N/A"
bid_size="N/A"
book_value="2.91"
change="+0.54"
change_from_200_day_moving_average="0.70"
change_from_50_day_moving_average="1.71"
change_from_52_week_high="-3.34"
change_From_52_week_low="3.39"
change_in_percent="+5.35%"
close="10.64"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.64"
ebitda="0.00"
eps_estimate_current_year="-1.99"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-1.85"
ex_dividend_date="N/A"
float_shares="3362000"
high="10.64"
high_52_weeks="13.98"
last_trade_date="1/27/2017"
last_trade_price="10.64"
last_trade_size="126"
last_trade_time="3:59pm"
low="10.10"
low_52_weeks="7.25"
market_capitalization="98.63M"
moving_average_200_day="9.94"
moving_average_50_day="8.93"
name="Gemphire Therapeutics Inc."
notes="N/A"
one_year_target_price="19.75"
open="10.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+7.02%"
percent_change_from_50_day_moving_average="+19.13%"
percent_change_from_52_week_high="-23.89%"
percent_change_from_52_week_low="+46.76%"
previous_close="10.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.47"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9270000"
short_ratio="0.36"
stock_exchange="NGM"
symbol="GEMP"
volume="5619"
weeks_range_52="7.25 - 13.98"
